Nuzenio

Processa Pharmaceuticals Acquires

Processa Pharmaceuticals Acquires news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 13 latest news signals 12 publisher sources 100/100 entity strength

Latest news

Inizio Engage launches Connected Insights | PharmExec - Pharmaceutical ExecutivePharmaceutical Executive · Thu, 30 Jul 2026 17:57:09 GMTProcessa acquires CNS-penetrant BTK inhibitor VT-7208 with USD 200m financing for three Phase II programs - AllSciAllSci · Thu, 30 Jul 2026 16:13:05 GMTProcessa acquires Vidya and its BTK inhibitor - The Pharma LetterThe Pharma Letter · Thu, 30 Jul 2026 12:02:43 GMTM&A Roundup: Johnson & Johnson Collaborates with Sail Biomedicines, Processa Pharmaceuticals Acquires Vidya Therapeutics, Relation Collaborates with GSK - Pharmaceutical ExecutivePharmaceutical Executive · Thu, 30 Jul 2026 07:00:00 GMTProcessa Pharmaceuticals Acquires Vidya Therapeutics And Raises About $200 Million To Advance VT-7208 - Pulse 2.0Pulse 2.0 · Wed, 29 Jul 2026 16:55:02 GMTProcessa acquires Vidya for potential rival to Rhapsido - Fierce BiotechFierce Biotech · Wed, 29 Jul 2026 14:10:16 GMTProcessa Pharmaceuticals Acquires Vidya Therapeutics, Secures $200 Million to Advance BTK Pipeline - citybizcitybiz · Wed, 29 Jul 2026 13:09:03 GMTPROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. AND APPROXIMATELY $200 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE BTK INHIBITOR, VT-7208, IN MULTIPLE DISEASE AREA - GlobeNewswireGlobeNewswire · Wed, 29 Jul 2026 11:30:00 GMT

Timeline

Thu, 30 Jul 2026 17:57:09 GMTInizio Engage launches Connected Insights | PharmExec - Pharmaceutical Executive
Thu, 30 Jul 2026 16:13:05 GMTProcessa acquires CNS-penetrant BTK inhibitor VT-7208 with USD 200m financing for three Phase II programs - AllSci
Thu, 30 Jul 2026 12:02:43 GMTProcessa acquires Vidya and its BTK inhibitor - The Pharma Letter
Thu, 30 Jul 2026 07:00:00 GMTM&A Roundup: Johnson & Johnson Collaborates with Sail Biomedicines, Processa Pharmaceuticals Acquires Vidya Therapeutics, Relation Collaborates with GSK - Pharmaceutical Executive
Wed, 29 Jul 2026 16:55:02 GMTProcessa Pharmaceuticals Acquires Vidya Therapeutics And Raises About $200 Million To Advance VT-7208 - Pulse 2.0
Wed, 29 Jul 2026 14:10:16 GMTProcessa acquires Vidya for potential rival to Rhapsido - Fierce Biotech

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Processa Pharmaceuticals Acquires.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

12 distinct publisher/source names are currently connected to this entity page.